x

Search for a clinical trial

* (*) mandatory field

Phase II pharmacokinetic study to assess doxorubicin clearance age-dependency in pediatric patients with solid tumours and leukemia - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : UniversitÄtsklinikum mÜnster
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Mr Nicolas ANDRE
  • Service d'oncologie pédiatrique
  • CHU de Marseille - Hôpital de la Timone
  • 264 rue Saint-Pierre
  • 13385 MARSEILLE CEDEX 5
  • FRANCE
  • More information
  • Phone  : 33 (0)4 91 38 68 21
  • Fax  : 33 (0)4 91 38 68 32
  • Website
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.